Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (201-210 of 320) with videos related to

Pageof 32
Sort By:
BMC Cancer|May 20, 2015
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasmsRobertson Mackenzie, Stefan Kommoss, Boris J Winterhoff, et al.
The Journal of Pathology|July 28, 2011
Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalitiesKasmintan A Schrader, Alireza Heravi-Moussavi, Paula J Waters, et al.
The Journal of Pathology|April 2, 2021
Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencingKatherine Dixon, Tom Brew, David Farnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management GuidelinesMarc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Nature Communications|April 26, 2020
Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancerRosario I Corona, Ji-Heui Seo, Xianzhi Lin, et al.
Science Signaling|September 28, 2017
Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodiesAndrew M Waters, Irem Ozkan-Dagliyan, Angelina V Vaseva, et al.
Genome Research|July 26, 2014
TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence dataGavin Ha, Andrew Roth, Jaswinder Khattra, et al.
The American Journal of Surgical Pathology|September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangementCheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
The Journal of Pathology|March 8, 2011
Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomasMelissa K McConechy, Michael S Anglesio, Steve E Kalloger, et al.
Plos One|March 24, 2015
Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencingBrandon S Sheffield, Anna V Tinker, Yaoqing Shen, et al.
Pageof 32

Showing results (201-210 of 320) with videos related to

Sort By:
Pageof 32
BMC Cancer|May 20, 2015
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasmsRobertson Mackenzie, Stefan Kommoss, Boris J Winterhoff, et al.
The Journal of Pathology|July 28, 2011
Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalitiesKasmintan A Schrader, Alireza Heravi-Moussavi, Paula J Waters, et al.
The Journal of Pathology|April 2, 2021
Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencingKatherine Dixon, Tom Brew, David Farnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2020
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management GuidelinesMarc Tischkowitz, Sidong Huang, Susana Banerjee, et al.
Nature Communications|April 26, 2020
Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancerRosario I Corona, Ji-Heui Seo, Xianzhi Lin, et al.
Science Signaling|September 28, 2017
Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodiesAndrew M Waters, Irem Ozkan-Dagliyan, Angelina V Vaseva, et al.
Genome Research|July 26, 2014
TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence dataGavin Ha, Andrew Roth, Jaswinder Khattra, et al.
The American Journal of Surgical Pathology|September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangementCheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
The Journal of Pathology|March 8, 2011
Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomasMelissa K McConechy, Michael S Anglesio, Steve E Kalloger, et al.
Plos One|March 24, 2015
Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencingBrandon S Sheffield, Anna V Tinker, Yaoqing Shen, et al.
Pageof 32